H

Haleon

Global consumer health care products company

Project Manager - People Experience - People Experience

Full-TimePosted on 10/22/2026Deadline 10/31/26
No salary listed
Senior, Expert
Bengaluru, Karnataka, India
In Person
Project & Program ManagementProject Management

About the job

Requirements
  • Eight to ten years of experience delivering complex transformation, organisational change, process improvement, and/or technology-enabled projects within large global organisations.
  • Fully qualified project manager with a recognised certification such as PMP, PRINCE2, Agile, Scrum, or equivalent.
  • Strong experience leading projects involving process redesign, operating model change, service transformation, HR technology, and/or employee experience improvements.
  • Proven ability to manage project budgets, governance forums, executive stakeholders, risks, issues, dependencies, and delivery teams.
  • Experience developing and managing detailed project plans, dashboards, status reporting, and benefits realisation frameworks.
  • Strong understanding of change management, stakeholder engagement, and adoption approaches.
  • Analytical mindset with the ability to interpret data, identify trends, and translate insights into action.
  • Strong project leadership skills with the ability to influence without authority and drive results through cross-functional teams.
  • Excellent stakeholder management capabilities, including the ability to engage and influence senior leaders.
  • Strong communication and storytelling skills, capable of translating complexity into clear and compelling messages.
  • Commercially minded and outcome-focused, with a focus on value and impact.
  • Highly organised and able to manage multiple priorities in complex, fast-moving environments.
  • Curious, pragmatic, and solutions-focused, with a passion for continuous improvement.
  • Resilient and adaptable, comfortable navigating ambiguity, change, and competing priorities.
  • Strong customer mindset with a genuine passion for creating better employee and manager experiences.
  • Demonstrates accountability, ownership, and a commitment to delivering high-quality outcomes.
Responsibilities
  • Lead the end-to-end delivery of complex People Solutions projects, ensuring scope, timelines, budgets, and expected outcomes are achieved.
  • Translate strategic priorities into clear project plans, delivery roadmaps, milestones, and measurable success criteria, embedding customer experience and adoption considerations from the outset.
  • Partner with Global Process Owners, HR leaders, Centres of Excellence, Digital & Technology, and wider stakeholders to shape and deliver people-centric solutions.
  • Establish and maintain project governance, including steering committees, project forums, RAID logs, action trackers, decision logs, and reporting.
  • Proactively manage project risks, issues, dependencies, resources, and budgets, resolving obstacles and escalating where required.
  • Drive delivery across multiple workstreams, ensuring alignment, accountability, and execution against agreed plans.
  • Use employee feedback, customer insights, operational metrics, and business data to inform project decisions and optimise outcomes.
  • Lead stakeholder engagement activities to build alignment, create commitment, and support delivery across complex global environments.
  • Partner with change and communications teams to develop adoption strategies that maximise readiness, engagement, and long-term success.
  • Measure and track benefits realisation, ensuring initiatives deliver improvements in experience, efficiency, service, and business performance.
  • Identify opportunities to simplify processes, remove friction, standardise ways of working, and improve service delivery across People Solutions.
  • Champion project management excellence by embedding consistent tools, methodologies, governance standards, and delivery practices across the portfolio.
Desired Qualifications
  • Experience with Workday, ServiceNow, or other enterprise HR technology platforms.

About the company

Haleon is a global consumer health company that develops and sells everyday health products under brands such as Sensodyne, Advil, and Centrum. Its products address oral care, pain relief, immunity, and general well-being, working through science-backed formulations people use daily. Haleon differentiates itself by being a focused, standalone consumer health business formed from GSK’s spin-off and built from leading brands through major acquisitions, operating at scale with a portfolio of category leaders and competing with peers like Kenvue and Procter & Gamble. Its goal is to help people take control of their daily health with trusted products, while expanding its global reach and investing in manufacturing capacity and brand development.

Company Size

10,001+

Company Stage

IPO

Headquarters

Weybridge, United Kingdom

Founded

2022

Get referred to Haleon

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 NielsenIQ data showed U.S. share rose to 12.0% from 11.4%.
  • CVS GLP-1 destination shelves delivered a 24% sales lift per store in Q1 2026.
  • H1 2026 organic revenue grew 2.6%, with North America accelerating to 3.1% in Q2.

What critics are saying

  • June 2026 Gas-X recall exposed packaging contamination and bruises trust in core digestive brands.
  • July 2026 decongestant litigation revived claims against Advil Sinus Congestion & Pain in Brooklyn.
  • Heavy promotions covered over 21% of U.S. sales in Q2, risking margin erosion and dependence.

What makes Haleon unique

  • Haleon owns sticky cash brands Sensodyne, Advil, TUMS, Centrum, and Biotène across categories.
  • July 2026 results showed 66.5% gross margin and 24.3% adjusted operating margin.
  • September 2026 retailer resets and CVS GLP-1 shelving show elite U.S. channel execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • Paid Parental Leave
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
CCentral
Oct 23rd, 2026
Haleon's focus on household convenience.

Haleon's focus on household convenience. Inside 'Health House': Haleon's immersive brand activation in Parkdale, Toronto connects OTC brands to everyday self-care. 10/23/2026 Haleon wants consumers to know that they understand the role convenience stores play in household remedies. That urgent run from the house for that emergency bottle of over-the-counter medicine is especially top of mind during flu season. Bringing household remedy brands under one roof. On October 23, Haleon Canada created Health House, a one-day immersive experience that brought all their brands under one roof. The ordinary-looking house in Parkdale showcased household brands in their natural habitat. The children's bedroom featured Children's Advil and Junior Advil; Adult and children's versions of Buckley's cough syrup were located in the bathroom; Centrum vitamins, VoltaCare and Voltaren were placed in the master bedroom. Bridging the gap between consumer awareness and the Haleon brand. While consumers may be familiar with Haleon's products, they're less familiar with Haleon itself. The brand activation helps store operators and consumers put the popular names to Haleon's brand. "The interactive experience is meant to get us closer to our consumers because we know the importance of hearing from them and understanding their needs," said Sarey Wulf, head of corporate affairs at Haleon Canada "But, we also help the consumer understand a little bit more preventative health and the importance of self-care." Packaging trends: Portability, single-dose options and affordability. Wulf recognizes the growing trend toward travel-size and smaller, single-dose options. "We recognize convenience stores operate in this unique environment. There's limited shelf space, it's a quick grab, something small and compact in a lot of cases. As shopping habits evolve, we're continuing to assess our own packaging formats. I think outside of the convenience store channel, people are looking for smaller pack sizes, broadly speaking, from an affordability perspective as well," reminds Wulf. "It's not only about portability, ease-of-use and convenience, but also there's an affordability component to small pack sizes and we're acutely aware of this as people's lifestyles change and affordability becomes more of a topic for Canadians." Expanding the lineup for cold and flu relief. Haleon's latest product portfolio highlights the August 2026 launch of Buckley's Cough & Mucus Relief Extra Strength (100 ml). Continuing their strong momentum, top-performing 2025 cough, cold and flu (CCF) innovations return to the lineup, including Buckley's Lozenges Extra Strength, Buckley's Nighttime Complete Extra Strength and Buckley's Nighttime Complete Extra Strength Plus Mucus Relief. Beyond core CCF, Haleon is expanding into adjacent categories with three new additions: Advil Migraine & Headache fast-acting liquid gel capsules, VoltaCare Cooling Cream for instant-contact muscle, joint and back pain relief as well as a reformulated Centrum Adult 50+ Complete Multivitamin. Retailer strategy: Securing supply chains and managing seasonal demand. "I think these brands have consistently resonated in the convenience shopper landscape, where people are seeking accessible, quick solutions," adds Wulf. "I'd say more broadly, we're seeing Canadians take a more proactive approach to self-care: Cough and cold season is a really good example of that. People prepare for this season. They know kids are back in school. They know they need to work and continue on with life as symptoms present. We continue to really work closely with our retail partners, including convenience, to just make sure that Canadians can access the products they rely on where they are when they're there." For retailers who know that an uptick in colds and flu means taking care of their inventory and ensuring customers can locate OTC remedies easily. Wulf emphasizes the role inventory plays for the company as well as for the convenience channel. "There's been a number of disruptions globally and it's definitely top of mind for folks. I would say reliable access to everyday health products is our number one priority,"states Wulf. "We are laser-focused on making sure that our customers and consumers can access our products, especially when demand increases, because we know that predictability: Demand increases in the fall." The household setting really "brought home" the point that Canadians are looking for convenience in part of their daily routine. "I think the conversation doesn't end at the house," added Wulf. "It's a two day activation that we hope that people will take with them the need to practice self care." Wulf adds that she hopes the attendees felt empowered by the activation. "I think the convenience retailer plays a really important role in that journey."

exchange4media
Oct 16th, 2026
Deep Malde joins Haleon as Head of Expert Marketing & Transformation.

Deep Malde joins Haleon as Head of Expert Marketing & Transformation. Malde joins Haleon from Mega LifeSciences, where he served as Business Head. Deep Malde has joined Haleon as Head of Expert Marketing & Transformation, bringing experience across consumer healthcare, nutrition, brand strategy and business transformation. Announcing the move on LinkedIn, Malde said he looked forward to nurturing the company's iconic brands to deliver its purpose of providing "better everyday health - with humanity". Malde joins Haleon from Mega LifeSciences, where he served as Business Head from January 2025 to May 2026, overseeing business performance, P&L delivery, sales and marketing teams, and operational efficiency. Before that, he spent over eight years at Danone India in marketing leadership roles, most recently as Head of Marketing - Global Brands Portfolio. Earlier, Malde spent over three years at Abbott Nutrition International, working on the PediaSure portfolio across brand strategy, consumer marketing, healthcare professional engagement and digital activation.

Yahoo Finance
Oct 15th, 2026
Haleon's Excedrin launches nostalgic "My Little Headache" digital pet to promote fast-relief painkiller

Haleon, the consumer health group, has launched Excedrin Rapid Relief, an aspirin-free and caffeine-free pain reliever that uses patented Fast Release Technology. The product is promoted through "My Little Headache," a nostalgic digital pet that shows headache discomfort worsening and how fast relief helps. The campaign shows Haleon testing engagement-led marketing for new products. It follows new marketing leadership and an expanded Microsoft AI collaboration. Analysts see the launch as a confidence boost for brand-building and pricing power rather than a major near-term catalyst. Key risks remain: product quality after recent recalls, and high debt alongside continued dividends and buybacks. Five Simply Wall St Community members put Haleon's fair value between £3.03 and £6.26.

exchange4media
Oct 14th, 2026
Varun Mitra joins Nestlé South Asia as Head of Digital, Data and Analytics - Supply Chain.

Varun Mitra joins Nestlé South Asia as Head of Digital, Data and Analytics - Supply Chain. Before joining Nestlé, Mitra spent nearly six years at Haleon. Varun Mitra has joined Nestlé South Asia as Head of Digital, Data and Analytics - Supply Chain. He announced his new role on LinkedIn. Mitra has experience in digital transformation across consumer goods, retail and consulting. His functional expertise spans marketing, supply chain, manufacturing, sales and human resources. Before joining Nestlé, Mitra spent nearly six years at Haleon, where he most recently served as General Manager, IT, overseeing Commercial, Finance, QSC and Infrastructure. His earlier stints include roles at Accenture, Asian Paints, SAP and Infosys.

Yahoo Finance
Oct 14th, 2026
Haleon shares at $4.51 after 10.9% three-year return: DCF points to undervaluation

Haleon shares closed at £3.55, after delivering a 10.9% total return over the past three years. A discounted cash flow model suggests the consumer health group is worth substantially more than that. The company generated about £2.48b of free cash flow over the last twelve months. Analysts expect it to stay in the billions through the next decade, with steady growth. The stock trades at 19.3 times earnings. Views differ. The bull case puts the shares 31% undervalued, citing a productivity and AI programme that has already added 140 basis points of gross margin. The bear case calls them 15% overvalued, noting organic revenue growth of 2.6% in the first half of 2026, against an ambition of 4% to 6%.